These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15485926)

  • 1. FoxA proteins regulate H19 endoderm enhancer E1 and exhibit developmental changes in enhancer binding in vivo.
    Long L; Spear BT
    Mol Cell Biol; 2004 Nov; 24(21):9601-9. PubMed ID: 15485926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enhancer deletion affects both H19 and Igf2 expression.
    Leighton PA; Saam JR; Ingram RS; Stewart CL; Tilghman SM
    Genes Dev; 1995 Sep; 9(17):2079-89. PubMed ID: 7544754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.
    Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A
    Oncogene; 2000 Dec; 19(54):6376-85. PubMed ID: 11175353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX7 and SOX17 regulate the parietal endoderm-specific enhancer activity of mouse laminin alpha1 gene.
    Niimi T; Hayashi Y; Futaki S; Sekiguchi K
    J Biol Chem; 2004 Sep; 279(36):38055-61. PubMed ID: 15220343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF maintains differential methylation at the Igf2/H19 locus.
    Schoenherr CJ; Levorse JM; Tilghman SM
    Nat Genet; 2003 Jan; 33(1):66-9. PubMed ID: 12461525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental profile of H19 differentially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic expression and DNA methylation at the imprinted H19/Igf2 locus.
    Thorvaldsen JL; Fedoriw AM; Nguyen S; Bartolomei MS
    Mol Cell Biol; 2006 Feb; 26(4):1245-58. PubMed ID: 16449639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striking differences between the mouse and the human alpha-fetoprotein enhancers.
    Long L; Davidson JN; Spear BT
    Genomics; 2004 Apr; 83(4):694-705. PubMed ID: 15028291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
    Hark AT; Schoenherr CJ; Katz DJ; Ingram RS; Levorse JM; Tilghman SM
    Nature; 2000 May; 405(6785):486-9. PubMed ID: 10839547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms at the mouse Igf2/H19 locus.
    Kaffer CR; Grinberg A; Pfeifer K
    Mol Cell Biol; 2001 Dec; 21(23):8189-96. PubMed ID: 11689707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.
    Cirillo LA; Lin FR; Cuesta I; Friedman D; Jarnik M; Zaret KS
    Mol Cell; 2002 Feb; 9(2):279-89. PubMed ID: 11864602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an upstream enhancer in the mouse laminin alpha 1 gene defining its high level of expression in parietal endoderm cells.
    Niimi T; Hayashi Y; Sekiguchi K
    J Biol Chem; 2003 Mar; 278(11):9332-8. PubMed ID: 12519763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of H19 3' sequences in controlling H19 and Igf2 imprinting and expression.
    Verona RI; Bartolomei MS
    Genomics; 2004 Jul; 84(1):59-68. PubMed ID: 15203204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
    Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
    Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis.
    Hiemisch H; Schütz G; Kaestner KH
    EMBO J; 1997 Jul; 16(13):3995-4006. PubMed ID: 9233809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling.
    Kohler S; Cirillo LA
    J Biol Chem; 2010 Jan; 285(1):464-72. PubMed ID: 19897491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer blocking activity of the insulator at H19-ICR is independent of chromatin barrier establishment.
    Singh V; Srivastava M
    Mol Cell Biol; 2008 Jun; 28(11):3767-75. PubMed ID: 18378700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IPEB transcription factor regulating the intracisternal A particle gene during F9 cell differentiation is expressed at sites of lymphoid development.
    Kamat JP; Basu A; Satyamoorthy K; Xu MQ; Showe L; Howe CC
    Mol Reprod Dev; 1995 May; 41(1):8-15. PubMed ID: 7619510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
    Iwahori A; Fraidenraich D; Basilico C
    Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression.
    Guo Y; Costa R; Ramsey H; Starnes T; Vance G; Robertson K; Kelley M; Reinbold R; Scholer H; Hromas R
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3663-7. PubMed ID: 11891324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence logic at enhancers governs a dual mechanism of endodermal organ fate induction by FOXA pioneer factors.
    Geusz RJ; Wang A; Lam DK; Vinckier NK; Alysandratos KD; Roberts DA; Wang J; Kefalopoulou S; Ramirez A; Qiu Y; Chiou J; Gaulton KJ; Ren B; Kotton DN; Sander M
    Nat Commun; 2021 Nov; 12(1):6636. PubMed ID: 34789735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.